» Authors » Ajay Prakash

Ajay Prakash

Explore the profile of Ajay Prakash including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 177
Citations 1892
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma L, Prakash A, Medhi B
Indian J Pharmacol . 2025 Feb; 56(6):375-378. PMID: 39973825
No abstract available.
2.
Shetty Y, Kamat S, Tripathi R, Parmar U, Jhaj R, Banerjee A, et al.
Indian J Med Res . 2025 Feb; 160(6):637-638. PMID: 39913524
No abstract available.
3.
Rajaram S, Prakash A, Medhi B
Indian J Pharmacol . 2024 Dec; 56(5):309-311. PMID: 39687952
No abstract available.
4.
Zhu C, Troester A, Mott S, Jensen C, Prakash A, Hassan I, et al.
Ann Surg Oncol . 2024 Oct; 32(1):39-41. PMID: 39427029
No abstract available.
5.
Jain A, Dhir N, Singh H, Sharma A, Medhi B, Prakash A
Basic Clin Neurosci . 2024 Sep; 15(2):261-272. PMID: 39228456
Introduction: Valproic acid (VPA) is the most widely used chemical to develop the preclinical model of autism spectrum disorder (ASD). However, in addition to inducing autism, it causes different teratogenic...
6.
White M, Prathibha S, Gupta A, Prakash A, Ankeny J, LaRocca C, et al.
J Surg Res . 2024 Aug; 302:293-301. PMID: 39116829
Introduction: Up to 90% of patients undergo inadequate resection for incidentally diagnosed T1b-T3 gallbladder cancer (GBC). We evaluated whether adjuvant therapies (ATs) are associated with prolonged overall survival (OS) for...
7.
Sharma A, Arpitha R, Kumaran M, Prakash A, Parsad D
Arch Dermatol Res . 2024 Jun; 316(7):432. PMID: 38916667
No abstract available.
8.
Singh H, Raja A, Chauhan A, Jain A, Prakash A, Bhatia A, et al.
ACS Pharmacol Transl Sci . 2024 Jun; 7(6):1856-1863. PMID: 38898950
Drug-resistant epilepsy is a prominent challenge in chronic neurological disorders. Valproate, commonly used to treat epilepsy, can fail due to various side effects and interactions, necessitating the exploration of alternative...
9.
Saifuddin P, Prakash A, Samujh R, Gupta S, Suri V, Kumar R, et al.
J Assoc Physicians India . 2024 Jun; 72(6):62-68. PMID: 38881137
Background: Knowledge about the pattern of adverse events caused by medical devices (MDs) is limited in India. We aimed to assess the pattern of MD adverse events (MDAEs) in a...
10.
Ascione L, Guidi L, Prakash A, Trapani D, LoRusso P, Lou E, et al.
Am Soc Clin Oncol Educ Book . 2024 Jun; 44(3):e431766. PMID: 38828973
Antibody-drug conjugates (ADCs) have reshaped the cancer treatment landscape across a variety of different tumor types. ADCs' peculiar pharmacologic design combines the cytotoxic properties of chemotherapeutic agents with the selectivity...